Comparison of dosage regimen of levofloxacin in patients with respiratory tract infection
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: ZHANG, Yi (Naval General Hospital, Beijing, China)
To compare the pharmacokinetic and pharmacodynamic characteristics of levofloxacin (LVFX) 200 mg q12h vs 400 mg qd in the treatment of patients with respiratory tract infections. 24 patients were divided into two groups. 200 mg LVFX was administered to the patients in group 1 twice a day with intravenous infusion. 400 mg LVFX was administered to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.